I am very familiar with AF from way back. Think what you like, but his comments move share prices. I can't comment on his statements about IMUC and Seeking Alpha - don't know. But his points about phase I are true. It was a small number of patients; there was no control group; and scientifically no real conclusions can be drawn yet. Of course, those of us who are long this stock and understand the science and have done our DD already know this. But I am certain there are many speculators that don't know all the details and smart traders know that AF's comments move price. Why not trade on his comments?
The fact is that most patients who have received the treatment have survived much longer than average. If there were "no real conclusions" to be drawn, the drug wouldn't be approved for further testing. True, the drug isn't yet approved for sale on the market, but any patient with this cancer would obviously be eager to take it.
I agree that the drug looks phenomenal and I love the management team. But Ph I was for safety only; nothing to do with approval. I definitely want to be in this stock pre-phase II data release. I sold my shares at $3.55. Trying to decide when to buy back in. Not sure how much more - if any - downside we have left.
And I have owned other stocks that AF has done similar things to. It does indeed have the appearance of manipulation and control. Hopefully I can get in again at cheap prices.
that is why if you read between the lines nothing new was said in AF's comment on IMUC in his "mailbag article"
phase 1 was just set up to look at the safety of the drug. Phase 2 is to really determine if the drug really works. Adam knows that and that is why nothing was said about phase 2 set up. This was nothing more than a bear raid.
I got lucky and sold some of my trading shares at $3.70 and bought back at 3.25.